Status:
COMPLETED
Reno- and Vascular Protective Effect of a Vitamin-D-analogue in Moderate to Severe Chronic Kidney Disease
Lead Sponsor:
Erling Bjerregaard Pedersen
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Recently it has been documented that vitamin D has important functions in the human body that are unrelated to its primary effects in calcium homeostasis and bone mineralization. In clinical studies, ...
Eligibility Criteria
Inclusion
- Kidney disease corresponding to eGFR: 15-59 ml/min
- Albuminuria \> 30 mg/l
Exclusion
- Total parathyroidectomy
- Diabetes Mellitus
- Cancer
- Illicit drug or alcohol abuse
- Pregnancy og nursing
- Ongoing NSAID or corticosteroid treatment
- b-hemoglobin \< 6 mmol/l
- p-albumin \< 25 mmol/l
- Clinically significant hypercalcemia
- Office blood pressure \> 170/105 mmHg that despite antihypertensive treatment still is \> 170/105 mmHg when using home blood pressure measurements or 24-hour ambulatory blood pressure measurement.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01136564
Start Date
July 1 2010
End Date
December 1 2011
Last Update
January 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical Research
Holstebro, Holstebro, Denmark, 7500